- GLP
About
VectorB2B is a contract research organization based in Lisbon, Portugal, serving biotechnology, pharma, medical device and other health-product companies. It supports drug and product development from discovery and toxicology through manufacturing, clinical services, and portfolio management.
Services
Discovery
Translational research and contract services across multiple therapeutic areas and classes of molecules, including antibody discovery, phage display, antibody engineering, recombinant expression and purification, and preclinical PK and efficacy studies.
Toxicology
GLP and non-GLP preclinical toxicology studies, including in vivo toxicity, safety pharmacology, genotoxicity, and in vitro safety assays.
Chemistry Manufacturing
Manufactures biologic medicines in Portugal for downstream applications such as clinical trials.
Clinical Services
Full-service CRO support from study design and set-up through close-out and clinical study report, including project management, monitoring, data management, biostatistics, medical writing, and regulatory support.
Functional Service Providing
Clinical study support for hospitals and investigation centers, including site feasibility, recruitment, data management, trial master file updates, sample management, quality control, and regulatory/legal support.
R&D Portfolio Management Services
Strategic consulting and execution support for R&D portfolios, including R&D support, reformulation, repurposing, and new product development.
Integrated Solutions
Integrated drug discovery and development services covering the full value chain from bench to bedside.
Capabilities
- Assays and studies
- Toxicology · In vivo · ELISA · Free immobilization immunoassays · Antibody screening · FcRn binding assays · ADCC assays · ADCP assays · Agonist/blocking assays · Cell reporter assays · TEER measurement · Papp permeability assays
10 more
ADA screening · Neutralizing ADA detection · MIC · MBC · Antiviral screening · GLP toxicology · Non-GLP toxicology · Clinical trials · Real-world evidence projects · Observational studies - Therapeutic areas
- Oncology · Infectious diseases · Neurodegenerative disorders · Ophthalmologic disorders · Ophthalmology · Neurosciences · Medical Devices · Food Supplement · Cardiology · Biological Drugs · Gastroenterology
Instruments and platforms
- HPLC
- MRI
- PET
- SPECT
Modalities and species
- Modalities
- Small molecule · Antibody · Cell therapy · Recombinant protein
- Species and models
- Caco-2 · BBB models · Xenograft models · Primary cell cultures · 3D cell cultures · Alzheimer’s disease models · Parkinson’s disease models · Epilepsy models · Multiple sclerosis models · Amyotrophic lateral sclerosis models · Lymphoma models · Glioblastoma models
2 more
Breast cancer models · Lung cancer models
Certifications
As the company states them, with the certificate or registry record where there is one.
GLPSelf-reported
Scope: in vivo toxicology facility
Industries served
- Biotechnology
- Pharma
- Medical device
- Health products
- Hospitals
- Investigation centers
- Cosmetics
- Cannabis
- Food supplements
- Animal health
Company
- Type
- CRO
- Founded
- 2019
Locations
- Based in
- Lisbon, Portugal
- Sites
- Lisboa, Portugal
- Serves
- Portugal, Europe
Contacts
- General enquiry
- info@vectorb2b.com on their site
- Phone
- +351 210 976 863
Similar labs
Work here? Claim this listing